These findings highlight the potential therapeutic role of vitamin B12 as an epidrug in attenuating hyperinflammation, providing promising directions for further research in neuroinflammatory conditions associated with long COVID
Clinical trials have shown that tirzepatide (Zepbound) achieves greater mean weight reduction compared to semaglutide (Wegovy) in patients with obesity [6]
Koffler's philosophy is rooted in using Semaglutide therapy to facilitate safe and sustained weight loss
Available from: Skin Care - Africa | Statista Market Forecast [Internet]
Conditions under active investigation include prediabetes, heart failure with preserved ejection fraction, obstructive sleep apnoea, knee osteoarthritis, polycystic ovarian syndrome, and inflammatory bowel disease
It is unknown whether semaglutide or tirzepatide causes medullary thyroid carcinoma in humans